Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Return on Equity [ROE] (2020 - 2026)

Updated

Aligos Therapeutics (ALGS) posted Return on Equity [ROE] of -307.03% for Q3 2026, down 207.34 percentage points from -99.69% a year earlier and down 68.48 percentage points from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Aligos Therapeutics' Return on Equity [ROE] came in at -196.78%, up 219.36 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -56.76 percentage points (FY2020 to FY2025).
  • In prior years, Aligos Therapeutics' Return on Equity [ROE] was -416.13% in FY2024 (-326.80 pp), -89.33% in FY2023 (-22.74 pp), -66.59% in FY2022 (-3.49 pp) and -63.09% in FY2021 (+76.92 pp).
  • The Q3 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2024.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last three quarters, with an average year-over-year change of -36.90 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2025, with a gain of 1204.68 percentage points; the weakest was Q4 2024, with a drop of 1124.07 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -238.55% (Q2 2026), -211.71% (Q1 2026) and -38.56% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 19.33%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 5.63%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 21.60%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 72.13%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -31.17%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.66%
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - -307.03%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -307.03%
Jun 30, 2026 -238.55%
Mar 31, 2026 -211.71%
Dec 31, 2025 -38.56%
Sep 30, 2025 -99.69%
Jun 30, 2025 -68.03%
Mar 31, 2025 -121.84%
Dec 31, 2024 -1,243.24%
Sep 30, 2024 -131.04%
Jun 30, 2024 -119.25%
Mar 31, 2024 -131.17%
Dec 31, 2023 -119.18%
Sep 30, 2023 -130.70%
Jun 30, 2023 -105.98%
Mar 31, 2023 -88.09%
Dec 31, 2022 -85.07%
Sep 30, 2022 -86.08%
Jun 30, 2022 -86.99%
Mar 31, 2022 -80.47%
Dec 31, 2021 -63.57%
API Access

Aligos Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY